Velan Capital Investment Management
Latest statistics and disclosures from Velan Capital Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALIM, JSPR, PRAX, IWM, HRTX, and represent 71.42% of Velan Capital Investment Management's stock portfolio.
- Added to shares of these 10 stocks: JSPR (+$43M), PRAX (+$21M), IWM (+$21M), XBI (+$14M), TRML (+$7.3M), Outlook Therapeutics (+$6.0M), AQST, MIST, NVNO, KPRX.
- Started 10 new stock positions in JSPR, MIST, KPRX, PRAX, NVNO, Outlook Therapeutics, TRML, XBI, AQST, IWM.
- Reduced shares in these 10 stocks: Praxis Precision Medicines I (-$8.9M), Jasper Therapeutics (-$6.8M), QIPT (-$6.1M), LNTH (-$5.2M), MLTX, , GOSS, CABA, APLS, .
- Sold out of its positions in ANNX, APLS, CABA, CGEM, Edesa Biotech, GOSS, Icosavax, ImmunoGen, INBX, IOVA. Jasper Therapeutics, LNTH, MLTX, Praxis Precision Medicines I, QIPT, THC, IFRX.
- Velan Capital Investment Management was a net buyer of stock by $69M.
- Velan Capital Investment Management has $221M in assets under management (AUM), dropping by 79.65%.
- Central Index Key (CIK): 0001848809
Tip: Access up to 7 years of quarterly data
Positions held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 21 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Alimera Sciences Com New (ALIM) | 24.0 | $53M | 14M | 3.90 |
|
|
| Jasper Therapeutics Com New (JSPR) | 19.5 | $43M | NEW | 1.5M | 29.36 |
|
| Praxis Precision Medicines I Com New (PRAX) | 9.7 | $21M | NEW | 351k | 61.02 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 9.5 | $21M | NEW | 100k | 210.30 |
|
| Heron Therapeutics (HRTX) | 8.7 | $19M | 7.0M | 2.77 |
|
|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 6.4 | $14M | NEW | 150k | 94.89 |
|
| Adma Biologics (ADMA) | 4.6 | $10M | -11% | 1.5M | 6.60 |
|
| Tourmaline Bio (TRML) | 3.3 | $7.3M | NEW | 319k | 22.90 |
|
| Outlook Therapeutics | 2.7 | $6.0M | NEW | 500k | 11.94 |
|
| Optinose (OPTN) | 2.0 | $4.4M | -16% | 3.0M | 1.46 |
|
| Tela Bio (TELA) | 1.9 | $4.2M | 746k | 5.67 |
|
|
| Inspire Med Sys (INSP) | 1.7 | $3.9M | +17% | 18k | 214.79 |
|
| Aquestive Therapeutics (AQST) | 1.2 | $2.6M | NEW | 600k | 4.26 |
|
| Elevation Oncology (ELEV) | 1.2 | $2.6M | 497k | 5.13 |
|
|
| Inspiremd (NSPR) | 1.0 | $2.1M | 904k | 2.37 |
|
|
| Geron Corporation (GERN) | 0.7 | $1.7M | -35% | 500k | 3.30 |
|
| Milestone Pharmaceuticals (MIST) | 0.5 | $1.2M | NEW | 650k | 1.79 |
|
| Rezolute Com New (RZLT) | 0.5 | $1.0M | 400k | 2.55 |
|
|
| Envveno Medical (NVNO) | 0.4 | $937k | NEW | 172k | 5.44 |
|
| Kiora Pharmaceuticals Com New (KPRX) | 0.4 | $777k | NEW | 1.1M | 0.71 |
|
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.2 | $385k | 625k | 0.62 |
|
Past Filings by Velan Capital Investment Management
SEC 13F filings are viewable for Velan Capital Investment Management going back to 2021
- Velan Capital Investment Management 2024 Q1 filed May 14, 2024
- Velan Capital Investment Management 2023 Q3 filed Nov. 13, 2023
- Velan Capital Investment Management 2023 Q2 filed Aug. 11, 2023
- Velan Capital Investment Management 2023 Q1 filed May 15, 2023
- Velan Capital Investment Management 2022 Q4 filed Feb. 13, 2023
- Velan Capital Investment Management 2022 Q3 filed Nov. 14, 2022
- Velan Capital Investment Management 2022 Q2 filed Aug. 15, 2022
- Velan Capital Investment Management 2022 Q1 filed May 16, 2022
- Velan Capital Investment Management 2021 Q4 filed Feb. 14, 2022